AngioDynamics (ANGO) Stock Forecast & Price Target

AngioDynamics Inc. is experiencing significant growth in its customer base within both outpatient vascular laboratories (OBL) and hospital settings, which is positively impacting average selling prices (ASP). The company's gross margin is on an upward trajectory at 52.5% due to ongoing manufacturing improvement initiatives and a favorable revenue mix shift towards higher margin Med-Tech products. Furthermore, management is optimistic about the continued growth potential of its product offerings, as evidenced by new customer acquisitions, increased utilization among existing accounts, and successful price increases.

AngioDynamics faces a negative outlook primarily due to anticipated tariff headwinds amounting to $4M-$6M, which could adversely impact its financial performance. Furthermore, the company expects its inventory in the second half of fiscal 2026 to experience pressure from rising raw material costs, suggesting potential cost inflation challenges. Despite recently favorable sales driven by capital equipment, the reliance on these sales may indicate underlying demand issues for disposable products moving forward.